Ac-satoreotide is a first-in-class Actinium-labelled somatostatin receptor 2 antagonist targeting extensive-stage Small Cell Lung Cancer or Merkel Cell ...

Q4 2024 Management View CEO Guido Oelkers highlighted an 8% growth in Q4 revenues, driven primarily by hematology sales, and an adjusted EBITDA margin of 34%. He noted strong demand for Altuvoct and ...

Of the 118 biologics losing exclusivity over the next decade, only 10% have biosimilars in development, meaning a vast ...

The Orphan Winfrey Network’s hit dating series ‘Ready to Love’ is on it’s way to the city of brotherly love, Philadelphia. The show features Black men and women in their 30s and 40s looking for love.

With its rich culture, breathtaking sights and intriguing landmarks, it’s not surprising that France is on the travel bucket ...

As we grieve our losses, I’m comforted and humbled to know that the persecuted church is interceding on our behalf.

Public is encouraged to document orca sightings, which could help find the 2-year-old female calf last seen in fall, 2024 ...

Adolore BioTherapeutics (”Adolore” or the “Company”), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal excitability to restore balance to the PNS/CNS to treat the ...

In arid West Texas, water seeps and bubbles from old wells, sometimes carrying oil, brackish water or other pollutants to the surface. But the real danger lies underground — where oil, salt, and toxic ...

Cumberland Pharmaceuticals' Phase 2 trial shows ifetroban improves heart function in Duchenne muscular dystrophy patients.

Despite some market exclusivity concerns, GERN still has many years of sales ahead, unencumbered by generic competition.

A Boston-area biopharmaceutical firm has submitted a biologics license application to the FDA for its investigational, fully ...